| Study Type |
Title Study |
Study Description |
| Memory & Cognition Studies |
HOPE: Health Outreach Program
for the Elderly |
This longitudinal study increases our understanding of age related
changes in memory and thinking. It also serves as the
Center’s main research registry, where participants agree to be
contacted regarding other ADC-approved studies. |
| |
ADMIRE: Aging and Decision
Making |
The goal of this study is to examine the impact of cognition
(e.g., memory, language skills) on decision-making capacity
among older adults with and without memory problems. |
| |
ADNI: Alzheimer’s Disease Neuroimaging Initiative |
This nationwide study will test whether repeated imaging studies
as well as other biological markers, clinical and neuropsychological
testing can be combined to measure the progression
of mild cognitive impairment and early AD. |
| |
Understanding False Memory
in AD |
This study seeks to better understand why patients with AD
and other dementias frequently remember things that never
happened. The ultimate goal of this NIA sponsored study is to
provide the basis for ways to reduce false memories in patients
with dementia. |
| Caregiving
Support & Education Studies |
Driving and Dementia: Assisting
Dementia Caregivers with the
Driving Decision |
A study which will involve educational materials and small
educational groups for caregivers aimed at informing them
about how to determine if their loved one should continue to
drive and how best to act on the decision to have the loved
one stop driving. |
| Genetic Studies |
MIRAGE: Multi-institutional
Research in AD Genetic
Epidemiology |
This longstanding, federally funded study evaluates the association
between genetic (hereditary) and non-genetic risk factors
for Alzheimer’s disease. The study is being conducted at multiple
sites in the U.S. and abroad. |
| |
LOAD: Late-onset AD genetics study |
This nationwide study collects genetic and clinical information
with the goal of understanding Alzheimer’s disease genetic and
environmental risk factors. |
|
Treatment
Studies |
CLASP: Cholesterol Lowering Agent
to Slow the Progression of AD |
This study tests the usefulness of simvastatin, a cholesterol lowering
drug, as a treatment to slow the progression of
Alzheimer’s disease. |
| |
MYRIAD (Flurizan™) |
The MYRIAD Study is a multi-national, multi-center study that
will evaluate the effectiveness of a new medication, Flurizan, in
slowing the progression of Alzheimer’s disease. |
